Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
Phathom Pharmaceuticals
PHAT
$692M
| $776K | ﹤0.01% |
69,188
-23,242
| -25% | -$240K |
|
4852
ACNB Corp
ACNB
$655M
| $775K | ﹤0.01% |
19,465
-216
| -1% | -$7.88K |
|
4853
Kodak
KODK
$983M
| $770K | ﹤0.01% |
252,476
-48,375
| -16% | -$213K |
|
4854
Cambria Global Value ETF
GVAL
$596M
| $767K | ﹤0.01% |
38,253
+875
| +2% | +$16.1K |
|
4855
Polestar Automotive Holding UK
PSNY
$2.06B
| $766K | ﹤0.01% |
4,806
-3,518
| -42% | -$569K |
|
|
FIRY
4856
Firy Inc
FIRY
$163M
| $765K | ﹤0.01% |
75,556
+2,775
| +4% | +$51K |
|
4857
Bausch + Lomb
BLCO
$5.99B
| $764K | ﹤0.01% |
49,276
-5,073
| -9% | -$76.2K |
|
4858
5E Advanced Materials
FEAM
$62.3M
| $763K | ﹤0.01% |
4,210
-2,053
| -33% | -$507K |
|
|
MGF
4859
Aberdeen Government Markets Income Fund
MGF
$92.2M
| $762K | ﹤0.01% |
230,183
+117,025
| +103% | +$385K |
|
4860
ARS Pharmaceuticals
SPRY
$612M
| $761K | ﹤0.01% |
89,214
+33,119
| +59% | +$215K |
|
4861
Lyell Immunopharma
LYEL
$360M
| $760K | ﹤0.01% |
10,944
-9,810
| -47% | -$974K |
|
4862
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$618M
| $759K | ﹤0.01% |
17,306
-4,598
| -21% | -$202K |
|
|
DBVT
4863
DBV Technologies
DBVT
$847M
| $759K | ﹤0.01% |
49,584
-3,592
| -7% | -$52.8K |
|
4864
VanEck International High Yield Bond ETF
IHY
$43.4M
| $758K | ﹤0.01% |
38,464
+9,518
| +33% | +$180K |
|
4865
RBB Bancorp
RBB
$455M
| $757K | ﹤0.01% |
36,300
+9,916
| +38% | +$216K |
|
4866
ProShares S&P Kensho Cleantech ETF
CTEX
$5.34M
| $756K | ﹤0.01% |
25,000
| – | – |
|
|
BRFS
4867
DELISTED
BRF SA
BRFS
| $755K | ﹤0.01% |
478,156
+109,156
| +30% | +$226K |
|
4868
Clarus
CLAR
$143M
| $755K | ﹤0.01% |
96,327
-186,171
| -66% | -$1.81M |
|
4869
Rocky Brands
RCKY
$369M
| $753K | ﹤0.01% |
31,894
-34,438
| -52% | -$798K |
|
4870
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$869M
| $752K | ﹤0.01% |
35,161
+10,332
| +42% | +$220K |
|
|
RAD
4871
DELISTED
Rite Aid Corporation
RAD
| $749K | ﹤0.01% |
224,268
-49,114
| -18% | -$233K |
|
4872
Dyne Therapeutics
DYN
$4.9B
| $747K | ﹤0.01% |
64,430
-65,110
| -50% | -$753K |
|
4873
TherapeuticsMD
TXMD
$24M
| $746K | ﹤0.01% |
133,481
-3,107
| -2% | -$18.3K |
|
|
KRON
4874
DELISTED
Kronos Bio
KRON
| $745K | ﹤0.01% |
459,667
+214,017
| +87% | +$493K |
|
4875
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$95.1M
| $744K | ﹤0.01% |
36,379
+405
| +1% | +$8.26K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.